View Alert
Originator: DHSC Supply Disruption Alert

Issue date: 06-Jun-2019 15:30:05

Action by recipients:
  • Care Trusts
  • Mental Health Trusts
  • Specialists Trusts
  • NHS Regional Offices
  • Learning Disabilities Trusts
  • Mental Health & Social Care Trusts
  • Ambulance Trusts
  • Mental Health & Learning Disabilities
  • Acute Trusts
  • Community Trusts

Information to recipients:
  • MHRA (Medicines) Drug Alerts (Various Recipients)
  • Other contacts
  • Independent Healthcare Providers (registered with CAS)
  • Clinical Commissioning Groups
  • Ofsted recipients
  • Social Care Providers (registered with CAS)
  • Special Health Authorities
  • Director of Public Health

Action category: Immediate Action

Title: Epanutin (phenytoin) 30mg/5ml oral suspension - supply disruption

Broadcast content: Pfizer Epanutin® (phenytoin) 30mg/5ml oral suspension will be out of stock from the week commencing 10 June 2019 until late July 2019.

This alert gives advice for all healthcare professionals who prescribe, dispense or administer Epanutin oral suspension. The alert also makes reference to unlicensed preparations, the Patient Information Leaflet (PIL) and product monograph is also attached.


Additional information: NHS Regional Offices: please cascade to GPs and Pharmacy.

Alert reference: SDA/2019/001

Action underway deadline: 11-Jun-2019

Action complete deadline: 31-Jul-2019

Attachments:

Contact our helpdesk

Email: safetyalerts@mhra.gov.uk

Medicines and Healthcare products Regulatory Agency